Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $12.48 billion. The enterprise value is $11.54 billion.
| Market Cap | 12.48B |
| Enterprise Value | 11.54B |
Important Dates
The last earnings date was Wednesday, October 30, 2024, before market open.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 101.25 million shares outstanding. The number of shares has increased by 2.91% in one year.
| Current Share Class | 101.25M |
| Shares Outstanding | 101.25M |
| Shares Change (YoY) | +2.91% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 1.04% |
| Owned by Institutions (%) | 93.98% |
| Float | 100.09M |
Valuation Ratios
The trailing PE ratio is 33.07 and the forward PE ratio is 15.79. NBIX's PEG ratio is 0.27.
| PE Ratio | 33.07 |
| Forward PE | 15.79 |
| PS Ratio | 5.50 |
| Forward PS | 5.07 |
| PB Ratio | 4.59 |
| P/TBV Ratio | 4.66 |
| P/FCF Ratio | 28.36 |
| P/OCF Ratio | 26.20 |
| PEG Ratio | 0.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.38, with an EV/FCF ratio of 26.22.
| EV / Earnings | 29.91 |
| EV / Sales | 5.15 |
| EV / EBITDA | 18.38 |
| EV / EBIT | 19.16 |
| EV / FCF | 26.22 |
Financial Position
The company has a current ratio of 4.37, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.37 |
| Quick Ratio | 3.98 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | 0.65 |
| Interest Coverage | 130.93 |
Financial Efficiency
Return on equity (ROE) is 16.35% and return on invested capital (ROIC) is 14.26%.
| Return on Equity (ROE) | 16.35% |
| Return on Assets (ROA) | 11.79% |
| Return on Capital (ROIC) | 14.26% |
| Revenue Per Employee | $1.60M |
| Profits Per Employee | $275,643 |
| Employee Count | 1,400 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 19.20 |
Taxes
In the past 12 months, NBIX has paid $135.70 million in taxes.
| Income Tax | 135.70M |
| Effective Tax Rate | 26.02% |
Stock Price Statistics
The stock price has increased by +13.17% in the last 52 weeks. The beta is 0.35, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +13.17% |
| 50-Day Moving Average | 118.48 |
| 200-Day Moving Average | 133.47 |
| Relative Strength Index (RSI) | 54.55 |
| Average Volume (20 Days) | 1,101,625 |
Short Selling Information
The latest short interest is 2.48 million, so 2.45% of the outstanding shares have been sold short.
| Short Interest | 2.48M |
| Short Previous Month | 2.62M |
| Short % of Shares Out | 2.45% |
| Short % of Float | 2.48% |
| Short Ratio (days to cover) | 2.86 |
Income Statement
In the last 12 months, NBIX had revenue of $2.24 billion and earned $385.90 million in profits. Earnings per share was $3.73.
| Revenue | 2.24B |
| Gross Profit | 1.53B |
| Operating Income | 602.30M |
| Pretax Income | 446.90M |
| Net Income | 385.90M |
| EBITDA | 628.00M |
| EBIT | 602.30M |
| Earnings Per Share (EPS) | $3.73 |
Balance Sheet
The company has $1.23 billion in cash and $286.20 million in debt, giving a net cash position of $941.80 million or $9.30 per share.
| Cash & Cash Equivalents | 1.23B |
| Total Debt | 286.20M |
| Net Cash | 941.80M |
| Net Cash Per Share | $9.30 |
| Equity (Book Value) | 2.72B |
| Book Value Per Share | 26.87 |
| Working Capital | 1.45B |
Cash Flow
In the last 12 months, operating cash flow was $476.40 million and capital expenditures -$36.30 million, giving a free cash flow of $440.10 million.
| Operating Cash Flow | 476.40M |
| Capital Expenditures | -36.30M |
| Free Cash Flow | 440.10M |
| FCF Per Share | $4.35 |
Margins
Gross margin is 68.07%, with operating and profit margins of 26.85% and 17.21%.
| Gross Margin | 68.07% |
| Operating Margin | 26.85% |
| Pretax Margin | 23.26% |
| Profit Margin | 17.21% |
| EBITDA Margin | 28.00% |
| EBIT Margin | 26.85% |
| FCF Margin | 23.34% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.91% |
| Shareholder Yield | -2.91% |
| Earnings Yield | 3.09% |
| FCF Yield | 3.53% |
Analyst Forecast
The average price target for NBIX is $163.91, which is 32.95% higher than the current price. The consensus rating is "Buy".
| Price Target | $163.91 |
| Price Target Difference | 32.95% |
| Analyst Consensus | Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (5Y) | 15.73% |
| EPS Growth Forecast (5Y) | 44.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 11.35 and a Piotroski F-Score of 6.
| Altman Z-Score | 11.35 |
| Piotroski F-Score | 6 |